Nandrolone Phenylpropionate
| Price | Get Latest Price |
| Package | 1Kg/Bag |
| Min. Order: | 100g/Bag |
| Supply Ability: | 1000KG |
| Update Time: | 2021-11-12 |
Product Details
| Product Name: Nandrolone Phenylpropionate | CAS No.: 62-90-8 |
| Min. Order: 100g/Bag | Purity: 99.4% |
| Supply Ability: 1000KG | Release date: 2021/11/12 |
The basic information
Chinese name Phenylpropionate Noron molecular formula C27H34O3CAS 62-90-8 molecular weight 406.56
Adaptive speech
Chronic wasting diseases, severe burns, before and after surgery, non-healing fractures and osteoporosis, premature infants, child stunting, etc. It can also be used for breast cancer that cannot be operated, functional uterine bleeding, uterine fibroids, etc.
Clinical application of speech
Adult intramuscular injection 25mg/ time, once every 1 ~ 2 weeks; Children, 10mg; For infants, 5mg each time.
Adverse speech
After use, women may have mild masculinization effects, such as acne, hirsutism, coarse voice, clitoral hypertrophy, amenorrhea or menstrual disorders, and other reactions, should be stopped immediately. Serum cholesterol may be elevated during treatment. The likelihood after long-term use causes icteric reach liver function obstacle, also may be water sodium retention causes oedema. Jaundice should be stopped immediately.
Precautions Voice
It should be used with caution in patients with liver and kidney diseases, congestive heart failure and benign prostatic hypertrophy. Serum cholesterol may increase during treatment, so it should be used with caution in patients with myocardial infarction or a history of coronary atherosclerosis. It should not be used in healthy children, because anabolic hormones can cause premature fusion of bone epiphyseal, affect body height, and promote precocious puberty or female masculinization.
Drug contraindication
Prostate cancer, male breast cancer, hypertension and pregnant women are forbidden.
Drug interaction speech
When combined with dicoumarin or indene dione derivatives, the anticoagulant activity was enhanced, and the dosage should be reduced when combined. When combined with oral hypoglycemic drugs or insulin, the hypoglycemic effect is enhanced, and the dose of hypoglycemic drugs and insulin should be adjusted when necessary. When used in combination with adrenal corticosteroids (especially salt corticosteroids), the incidence of edema and acne is increased. Combined with hepatotoxic drugs, can aggravate the damage to the liver.
Note: The above content is only for introduction, the use of drugs must be carried out in regular hospitals under the guidance of doctors.

Company Profile Introduction
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $37.00/10mg |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-02-01 | |
| $10.00/1box |
VIP1Y
|
Shanghai Zheng Peptide Plastic Co., Ltd.
|
2026-01-23 | |
| $1200.00/1kg |
VIP1Y
|
Hainan Fubai Trading Co., LTD
|
2025-11-24 | |
| $10.00/1box |
VIP1Y
|
Ningbo Qingteng Plastic Cost.,Ltd.
|
2025-08-06 | |
| $200.00/100G |
VIP1Y
|
Handan City Zechi trading Co., LTD
|
2025-07-03 | |
| $5.00/1Box |
VIP2Y
|
Hebei Jiafan Trading Company Limited
|
2025-05-15 | |
| $0.00/50g |
VIP1Y
|
Wuhan Kejiefeng Trading Co.,Ltd
|
2025-05-09 | |
| $0.00/1KG |
VIP2Y
|
Shaanxi Xianhe Biotech Co., Ltd
|
2025-04-16 | |
| $30.00/100g |
VIP1Y
|
Shenzhen Aoxi Technology Co., Ltd.
|
2025-03-24 | |
| $30.00/1KG |
Shandong Xuhuang New material CoLTD
|
2025-02-20 |
- Since: 2020-09-09
- Address: 301, Unit 2, Building 58, Xinggang Community, Futian Street, Yiwu, Zhejiang
15372914669
kt15372914669@163.com

China